Ipsen ($GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, ...
FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
NEW YORK, May 26 (Reuters) - Allergan Inc said on Tuesday that U.S. health regulators will require more information before approving its Botox anti-wrinkle drug as a treatment for upper limb ...
Botox is a household name synonymous with wrinkle reduction and a youthful appearance. However, this powerful medication, derived from a purified neurotoxin, has a surprising array of uses that extend ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback